Glenn van Langenhove, MD, PhD for the DELAYED RRISC (Dea
Articles
Late mortality with sirolimus-eluting stents in diseased saphenous vein grafts
Pierfrancesco Agostoni, MD;Paul Vermeersch, MD;Stefan Verheye, MD, PhD;Paul van den Heuvel, MD;Carl Convens, MD;Frank van den Branden, MD;Glenn van Langenhove, MD, PhD for the DELAYED RRISC (Dea
September 5th 2008In a secondary post-hoc analysis of the Reduction of Restenosis in Saphenous Vein Grafts with Cypher (RRISC) trial, we compared the long-term safety of sirolimus-eluting stents (SES) with bare-metal stents (BMS) in diseased saphenous vein grafts
Read More
Latest Updated Articles
Published: October 4th 2024 | Updated: October 14th 2024
Minimally Invasive Techniques to Manage Complex Polyps at Allegheny Health Network
Published: May 2nd 2024 | Updated: May 6th 2024
Cardiology Month in Review: April 2024
Published: November 16th 2024 | Updated: December 26th 2024
Hide Okuno, MS: Tube Weaning Reduces Parental Stress, Findings Guide Future Studies
Published: November 15th 2024 | Updated: December 26th 2024
Parent Stress Reduces Over Time When Weaning Child Off Tube Feeding with Hide Okuno, MS
Published: December 16th 2024 | Updated: December 26th 2024
Brilaroxazine Shows Long-Term Efficacy in Schizophrenia in Phase 3 RECOVER
Published: December 16th 2024 | Updated: December 26th 2024
FDA Approves Tapinarof 1% Cream for Adult, Pediatric Patients with Atopic Dermatitis
